Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun J Yang

Showing results (121-130 of 232) with videos related to

Pageof 24
Sort By:
British Journal of Haematology|July 29, 2022
Low NUDT15 expression levels due to biallelic NUDT15 variants and 6-mercaptopurine intoleranceMasanori Yoshida, Scott A Brown, Takaya Moriyama, et al.
Blood Advances|July 31, 2023
ETV6 represses inflammatory response genes and regulates HSPC function during stress hematopoiesis in miceMackenzie Bloom, Ninad Oak, Rebekah Baskin-Doerfler, et al.
Blood|May 12, 2020
Effects of germline DHFR and FPGS variants on methotrexate metabolism and relapse of leukemiaMorten Tulstrup, Takaya Moriyama, Chuang Jiang, et al.
Journal of the American Chemical Society|December 24, 2025
Direct-to-Biology Enabled Molecular Glue DiscoveryMaowei Hu, Jason Ochoada, Marisa Actis, et al.
The Lancet. Oncology|May 31, 2025
Contributions of cancer treatment and genetic predisposition to risk of subsequent neoplasms in long-term survivors of childhood cancer: a report from the St Jude Lifetime Cohort and the Childhood Cancer Survivor StudyAchal Neupane, Qi Liu, Siddhant Taneja, et al.
Leukemia|August 26, 2022
Epigenomic profiling of glucocorticoid responses identifies cis-regulatory disruptions impacting steroid resistance in childhood acute lymphoblastic leukemiaBrennan P Bergeron, Jonathan D Diedrich, Yang Zhang, et al.
Blood|March 25, 2018
Preclinical evaluation of <i>NUDT15</i>-guided thiopurine therapy and its effects on toxicity and antileukemic efficacyRina Nishii, Takaya Moriyama, Laura J Janke, et al.
Blood|May 28, 2025
Differentiation-dependent EBF1 activity determines CD22 transcription and leukemia sensitivity to inotuzumab ozogamicinCarolin S Escherich, Zhenhua Li, Kelly R Barnett, et al.
Cancer Research|October 17, 2020
Evolution of the Epigenetic Landscape in Childhood B Acute Lymphoblastic Leukemia and Its Role in Drug ResistanceShella Saint Fleur-Lominy, Nikki A Evensen, Teena Bhatla, et al.
Clinical Pharmacology and Therapeutics|January 31, 2026
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 UpdateMaud Maillard, Matthias Schwab, Michelle Whirl-Carrillo, et al.
Pageof 24

Showing results (121-130 of 232) with videos related to

Sort By:
Pageof 24
British Journal of Haematology|July 29, 2022
Low NUDT15 expression levels due to biallelic NUDT15 variants and 6-mercaptopurine intoleranceMasanori Yoshida, Scott A Brown, Takaya Moriyama, et al.
Blood Advances|July 31, 2023
ETV6 represses inflammatory response genes and regulates HSPC function during stress hematopoiesis in miceMackenzie Bloom, Ninad Oak, Rebekah Baskin-Doerfler, et al.
Blood|May 12, 2020
Effects of germline DHFR and FPGS variants on methotrexate metabolism and relapse of leukemiaMorten Tulstrup, Takaya Moriyama, Chuang Jiang, et al.
Journal of the American Chemical Society|December 24, 2025
Direct-to-Biology Enabled Molecular Glue DiscoveryMaowei Hu, Jason Ochoada, Marisa Actis, et al.
The Lancet. Oncology|May 31, 2025
Contributions of cancer treatment and genetic predisposition to risk of subsequent neoplasms in long-term survivors of childhood cancer: a report from the St Jude Lifetime Cohort and the Childhood Cancer Survivor StudyAchal Neupane, Qi Liu, Siddhant Taneja, et al.
Leukemia|August 26, 2022
Epigenomic profiling of glucocorticoid responses identifies cis-regulatory disruptions impacting steroid resistance in childhood acute lymphoblastic leukemiaBrennan P Bergeron, Jonathan D Diedrich, Yang Zhang, et al.
Blood|March 25, 2018
Preclinical evaluation of <i>NUDT15</i>-guided thiopurine therapy and its effects on toxicity and antileukemic efficacyRina Nishii, Takaya Moriyama, Laura J Janke, et al.
Blood|May 28, 2025
Differentiation-dependent EBF1 activity determines CD22 transcription and leukemia sensitivity to inotuzumab ozogamicinCarolin S Escherich, Zhenhua Li, Kelly R Barnett, et al.
Cancer Research|October 17, 2020
Evolution of the Epigenetic Landscape in Childhood B Acute Lymphoblastic Leukemia and Its Role in Drug ResistanceShella Saint Fleur-Lominy, Nikki A Evensen, Teena Bhatla, et al.
Clinical Pharmacology and Therapeutics|January 31, 2026
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 UpdateMaud Maillard, Matthias Schwab, Michelle Whirl-Carrillo, et al.
Pageof 24